3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Conditions:   Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Adult Solid Tumor, Protocol SpecificIntervention:   Device: 3'-deoxy-3'-[18F]fluorothymidineSponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI)Recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials